New drugs and dosage forms.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D004304:Dosage Forms; D024841:Fluoroquinolones; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use; D000077266:Moxifloxacin; D009883:Ophthalmic Solutions; D004364:Pharmaceutical Preparations; D011433:Propranolol / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D000519:alpha-Galactosidase / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001372:Aza Compounds; D004304:Dosage Forms; D024841:Fluoroquinolones; D007527:Isoenzymes; D009883:Ophthalmic Solutions; D004364:Pharmaceutical Preparations; D011804:Quinolines; D011433:Propranolol; D000519:alpha-Galactosidase; C459420:agalsidase beta; D000077266:Moxifloxacin